We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Xofluza was first discovered by Japanese drugmaker Shionogi and is currently being jointly developed and commercialized with the Roche Group. Read More
The group claimed Vertex would have to lower its nearly $249,000 price tag by up to 98.5 percent to meet the threshold for a quality-adjusted life-year. Read More
The FDA broke its generic drug approval record yet again, FDA Commissioner Scott Gottlieb said Thursday, reporting that fiscal 2018 has seen the most approvals and tentative approvals. Read More